Physician profile
Patrick E Hourani
NPI 1386975175
$14,513.74
in general payments reported to CMS, 2019-2025
43 companies · $2,321 in 2025
The $2,321 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,497 · 2020: $767 · 2021: $1,863 · 2022: $2,493 · 2023: $2,662 · 2024: $2,912 · 2025: $2,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,857 · Education: $37.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,856.69 |
| Education | $37.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,412.88 | 2021-2025 | Mycarelink, Linq II, Cardioblate Cryoflex |
| Boston Scientific Corporation | $1,534.67 | 2021-2025 | Watchman Access System, Electrophysiology Cable, Avvigo Guidance System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $798.25 | 2020-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $778.25 | 2019-2025 | Farxiga, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $777.06 | 2019-2025 | Jardiance |
| Pfizer INC. | $716.92 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $715.54 | 2019-2025 | Camzyos, Eliquis |
| Shockwave Medical, INC | $711.48 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $503.45 | 2022-2025 | Verquvo, Capvaxive |
| Janssen Pharmaceuticals, INC | $460.86 | 2019-2024 | Xarelto |
| Abbott Laboratories | $438.98 | 2019-2025 | Amplatzer Amulet |
| Medtronic Vascular, INC. | $353.43 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $327.78 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $303.91 | 2022-2025 | |
| Amgen INC. | $295.52 | 2022-2025 | Repatha, Repatha |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $270.54 | 2024-2025 | |
| Philips North America LLC | $207.30 | 2020-2025 | (Ck4) Mcot, Diagnostic Ecg Service |
| Akcea Therapeutics, INC. | $154.27 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $146.15 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $145.13 | 2024-2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $136.38 | 2022-2025 | Optimizer, Optimizer |
| Ge Healthcare | $129.78 | 2019-2020 | |
| Biosense Webster, INC. | $125.00 | 2024 | Carto 3 |
| Angiodynamics, INC. | $119.43 | 2019 | |
| Amarin Pharma, INC. | $101.52 | 2019 | |
| Cardiovascular Systems INC. | $100.99 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $90.05 | 2023-2024 | Inpefa |
| Cvrx, INC. | $82.20 | 2023-2024 | Barostim Neo System |
| Novo Nordisk INC | $76.92 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Vital Connect, INC | $67.68 | 2023-2025 | Vitalpatch Rtm |
| Esperion Therapeutics, INC. | $57.58 | 2020-2022 | |
| Atricure, INC. | $50.35 | 2022 | |
| Abiomed | $49.27 | 2020-2024 | Impella |
| Sanofi-Aventis U.S. LLC | $45.81 | 2019-2023 | |
| Scpharmaceuticals INC. | $37.77 | 2023-2024 | |
| Kiniksa Pharmaceuticals, Ltd. | $36.94 | 2023 | Arcalyst |
| Cardiva Medical, INC. | $34.91 | 2021-2025 | Savvywire |
| Glaxosmithkline, LLC. | $30.07 | 2025 | Shingrix, Arexvy |
| Cordis US Corp. | $21.88 | 2023 | Rain Sheath Transradial |
| Cook Medical LLC | $18.77 | 2020 | |
| Chiesi USA, INC. | $17.12 | 2021 | |
| Baxter Healthcare | $16.32 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Surmodics, INC. | $14.63 | 2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Pounce Venous Thrombectomy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Hourani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.